There were no differences between studies that did and did not report additional therapies regarding pre-treatment serum K+, pre-treatment serum glucose concentrations, type, doses, or rate of infusion of insulin and dextrose, diabetes status and kidney failure. The gene discussed is INS; the disease is kidney failure.